Refractory severe connective tissue disease thrombocytopenia: is rituximab treatment effective and safe?
Zheng
W J
WJ
Zhang
X
X
Wang
Q
Q
Xu
D
D
Zeng
X F
XF
Zhang
F C
FC
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000276:immunology; D003240:Connective Tissue Diseases / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000276:immunology; D055815:Young Adult
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab